• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从海洋真菌Gliocladium sp. T31 中分离到的新型 DNA 拓扑异构酶 I 抑制剂 secalonic acid D。

Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungus Gliocladium sp. T31.

机构信息

Beijing Key Laboratory of Plant Resource Research and Development, College of Chemical and Environmental Engineering, Beijing Technology and Business University, Beijing, China.

出版信息

Pharm Biol. 2011 Aug;49(8):796-9. doi: 10.3109/13880209.2010.548817. Epub 2011 Apr 15.

DOI:10.3109/13880209.2010.548817
PMID:21495809
Abstract

CONTEXT

DNA topoisomerase I (topo I) is an essential enzyme which regulates the conformational changes in DNA topology by cleaving and rejoining DNA strands during normal cell growth. The inhibitors of topo I represent a major class of anticancer drugs. In our projects to isolate new anticancer agents from marine-derived fungi, secalonic acid D (SAD) with inhibitory activity on topo I was isolated from the fermentation broth of marine lichen-derived fungus Gliocladium sp. T31, which was collected from marine sediments in South Pole.

OBJECTIVE

The inhibitory activity of SAD on topo I was investigated for the first time.

MATERIALS AND METHODS

The inhibitory effect of SAD on topo I was determined via in vitro supercoil relaxation assays and electrophoretic mobility shift assay (EMSA) using plasmid substrate, pBR322.

RESULTS

SAD displays a considerable inhibition on topo I in a dose-dependent manner with the minimum inhibitory concentration (MIC) of 0.4 µM. Unlike the prototypic DNA topo I poison camptothecin (CPT), SAD inhibits the binding of topo I to DNA but does not induce the formation of topo I-DNA covalent complexes.

DISCUSSION AND CONCLUSION

SAD is an excellent topo I inhibitor and thus a significantly potential anticancer candidate.

摘要

背景

DNA 拓扑异构酶 I(topo I)是一种必需的酶,它通过在正常细胞生长过程中切割和重新连接 DNA 链来调节 DNA 拓扑结构的构象变化。topo I 的抑制剂是一类主要的抗癌药物。在我们从海洋来源的真菌中分离新的抗癌剂的项目中,从南极海洋沉积物中采集的海洋地衣来源真菌Gliocladium sp. T31 的发酵液中分离到了具有 topo I 抑制活性的 secalonic 酸 D(SAD)。

目的

首次研究了 SAD 对 topo I 的抑制活性。

材料和方法

通过体外超螺旋松弛测定和电泳迁移率变动分析(EMSA)用质粒底物 pBR322 测定 SAD 对 topo I 的抑制作用。

结果

SAD 以剂量依赖性方式对 topo I 显示出相当的抑制作用,最小抑制浓度(MIC)为 0.4µM。与典型的 DNA topo I 毒物喜树碱(CPT)不同,SAD 抑制 topo I 与 DNA 的结合,但不诱导 topo I-DNA 共价复合物的形成。

讨论和结论

SAD 是一种优秀的 topo I 抑制剂,因此是一种很有潜力的抗癌候选药物。

相似文献

1
Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungus Gliocladium sp. T31.从海洋真菌Gliocladium sp. T31 中分离到的新型 DNA 拓扑异构酶 I 抑制剂 secalonic acid D。
Pharm Biol. 2011 Aug;49(8):796-9. doi: 10.3109/13880209.2010.548817. Epub 2011 Apr 15.
2
Secalonic acid D; A cytotoxic constituent from marine lichen-derived fungus Gliocladium sp. T31.黄绿蜜环菌素D;一种源自海洋地衣的真菌粘帚霉属菌株T31的细胞毒性成分。
Arch Pharm Res. 2006 Jan;29(1):59-63. doi: 10.1007/BF02977469.
3
New compound with DNA Topo I inhibitory activity purified from Penicillium oxalicum HSY05.从草酸青霉HSY05中纯化得到的具有DNA拓扑异构酶I抑制活性的新化合物。
Nat Prod Res. 2015;29(23):2197-202. doi: 10.1080/14786419.2015.1008472. Epub 2015 May 13.
4
Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.新型苯并氧杂蒽酮类似物的合成及其作为非喜树碱拓扑异构酶 I 抑制剂的研究。
J Enzyme Inhib Med Chem. 2012 Jun;27(3):437-42. doi: 10.3109/14756366.2011.595712. Epub 2011 Jul 20.
5
DNA topoisomerase I as one of the cellular targets of certain tyrphostin derivatives.DNA拓扑异构酶I作为某些 tyrphostin 衍生物的细胞靶点之一。
Mol Pharmacol. 2004 Sep;66(3):627-34. doi: 10.1124/mol.66.3..
6
Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.人DNA拓扑异构酶I:喜树碱类似物以及苯并菲啶生物碱盐酸两面针碱和6-乙氧基二氢两面针碱对DNA拓扑异构酶I诱导的DNA链断裂影响的定量分析
Arch Biochem Biophys. 1999 Oct 1;370(1):66-76. doi: 10.1006/abbi.1999.1355.
7
BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo.BN80927:一种新型的喜树碱类似物,可在体外和体内抑制人肿瘤细胞的增殖。
Cancer Res. 2004 Jul 15;64(14):4942-9. doi: 10.1158/0008-5472.CAN-03-3872.
8
TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells.TCH-1030 通过靶向拓扑异构酶 I 诱导乳腺癌细胞 S 期停滞、DNA 片段化和细胞死亡。
Breast Cancer Res Treat. 2013 Apr;138(2):383-93. doi: 10.1007/s10549-013-2441-1. Epub 2013 Feb 22.
9
CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity.CK2 介导的拓扑异构酶 I 过度磷酸化作用于丝氨酸 506 位,增强拓扑异构酶 I-DNA 结合,并增加细胞中喜树碱的敏感性。
PLoS One. 2012;7(11):e50427. doi: 10.1371/journal.pone.0050427. Epub 2012 Nov 21.
10
The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.新型聚(ADP - 核糖)聚合酶抑制剂AG14361通过增加DNA链断裂的持久性使细胞对拓扑异构酶I毒物敏感。
Clin Cancer Res. 2005 Dec 1;11(23):8449-57. doi: 10.1158/1078-0432.CCR-05-1224.

引用本文的文献

1
The Cytotoxic Activity of Secondary Metabolites from Marine-Derived spp.: A Review (2018-2024).海洋来源的[具体物种]次生代谢产物的细胞毒性活性综述(2018 - 2024年)
Mar Drugs. 2025 Apr 30;23(5):197. doi: 10.3390/md23050197.
2
Xanthone Dimers in Angiosperms, Fungi, Lichens: Comprehensive Review of Their Sources, Structures, and Pharmacological Properties.被子植物、真菌、地衣中的氧杂蒽酮二聚体:其来源、结构和药理特性的综合综述
Molecules. 2025 Feb 19;30(4):967. doi: 10.3390/molecules30040967.
3
Baeyer-Villiger oxidation: a promising tool for the synthesis of natural products: a review.
拜耳-维立格氧化反应:一种用于天然产物合成的有前景的工具:综述
RSC Adv. 2024 Jul 25;14(32):23423-23458. doi: 10.1039/d4ra03914a. eCollection 2024 Jul 19.
4
Polyketides with potential bioactivities from the mangrove-derived fungus sp. WHUF0362.来自红树林衍生真菌WHUF0362的具有潜在生物活性的聚酮化合物。
Mar Life Sci Technol. 2023 Mar 31;5(2):232-241. doi: 10.1007/s42995-023-00170-5. eCollection 2023 May.
5
Marine-Derived Xanthone from 2010 to 2021: Isolation, Bioactivities and Total Synthesis.海洋来源黄烷酮:2010 年至 2021 年的研究进展:分离、生物活性与全合成。
Mar Drugs. 2022 May 25;20(6):347. doi: 10.3390/md20060347.
6
Chemometric and Transcriptomic Profiling, Microtubule Disruption and Cell Death Induction by Secalonic Acid in Tumor Cells.色烯酸在肿瘤细胞中通过化学计量学和转录组学分析、微管破坏和细胞死亡诱导作用。
Molecules. 2020 Jul 15;25(14):3224. doi: 10.3390/molecules25143224.
7
Marine Natural Products as Models to Circumvent Multidrug Resistance.海洋天然产物作为克服多药耐药性的模型。
Molecules. 2016 Jul 8;21(7):892. doi: 10.3390/molecules21070892.
8
Can Some Marine-Derived Fungal Metabolites Become Actual Anticancer Agents?某些海洋来源的真菌代谢产物能成为真正的抗癌药物吗?
Mar Drugs. 2015 Jun 19;13(6):3950-91. doi: 10.3390/md13063950.
9
Marine natural products as breast cancer resistance protein inhibitors.海洋天然产物作为乳腺癌耐药蛋白抑制剂
Mar Drugs. 2015 Apr 3;13(4):2010-29. doi: 10.3390/md13042010.
10
Total syntheses of secalonic acids A and D.鬼臼毒素A和D的全合成。
Angew Chem Int Ed Engl. 2014 Mar 17;53(12):3107-10. doi: 10.1002/anie.201311260. Epub 2014 Feb 12.